Eli Lilly and Company
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Eli Lilly and Company's balance sheet done over the years? Its assets were worth $64,006,300,000 last year, which is more than in the previous period. 83% of Eli Lilly and Company’s total assets is currently financed by debt. Its liabilities reached the amount of $53,142,600,000, which means an increase by 37% compared compared to last year.
Debt to Assets
| 2014 | 37178200000 | 21.79B | 58.61% |
|---|---|---|---|
| 2015 | 35568900000 | 20.97B | 58.98% |
| 2016 | 38805900000 | 24.72B | 63.72% |
| 2017 | 44981000000 | 33.31B | 74.06% |
| 2018 | 43908400000 | 32.99B | 75.15% |
| 2019 | 39286100000 | 36.58B | 93.13% |
| 2020 | 46633100000 | 40.80B | 87.51% |
| 2021 | 48806000000 | 39.65B | 81.24% |
| 2022 | 49489800000 | 38.71B | 78.23% |
| 2023 | 64006300000 | 53.14B | 83.03% |
LLY.SW Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 2.81B | 2.06B | 3.81B | 3.65B | 2.33B | 7.32B | 6.53B | 4.58B | 3.66B | 3.87B |
Short term investments | 109.1M | 144.8M | 90.1M | 24.2M | 101M | 88.2M | 1.49B | 1.45B | 785.4M | 955.4M |
Net receivables | 11.33B | 8.55B | 8.12B | 6.92B | 5.54B | 5.77B | 4.54B | 4.76B | 3.51B | 3.23B |
Inventory | 5.77B | 4.30B | 3.88B | 3.98B | 3.19B | 3.09B | 4.45B | 3.56B | 3.44B | 2.74B |
Other current assets | 5.69B | 2.95B | 2.53B | 2.87B | 2.53B | 2.14B | 2.16B | 734.6M | 1.16B | 1.37B |
Total current assets | 25.72B | 18.03B | 18.45B | 17.46B | 13.70B | 20.54B | 19.20B | 15.10B | 12.57B | 12.17B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 12.91B | 10.14B | 8.98B | 8.68B | 8.40B | 7.99B | 8.82B | 8.25B | 8.05B | 7.96B |
Goodwill | 4.93B | 4.07B | 3.89B | 3.76B | 3.67B | 1.36B | 4.37B | 3.97B | 4.03B | 1.75B |
Intangible assets | 6.90B | 7.20B | 7.69B | 7.45B | 6.61B | 1.06B | 4.02B | 4.35B | 5.03B | 2.88B |
Long term investments | 3.40B | 2.90B | 3.21B | 2.96B | 1.96B | 2.00B | 5.67B | 5.20B | 3.64B | 4.56B |
Other non-current assets | 10.11B | 4.33B | 4.08B | 3.47B | 2.33B | 8.30B | 2.87B | 1.91B | 2.22B | 7.82B |
Total non-current assets | 38.27B | 31.45B | 30.35B | 29.17B | 25.57B | 23.35B | 25.77B | 23.70B | 22.99B | 24.99B |
Total assets | 64.00B | 49.48B | 48.80B | 46.63B | 39.28B | 43.90B | 44.98B | 38.80B | 35.56B | 37.17B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 8.81B | 8.11B | 6.68B | 404M | 6.58B | 5.47B | 4.42B | 4.91B |
Short term debt | 6.90B | 1.50B | 1.53B | 8.7M | 1.49B | 1.10B | 3.74B | 1.93B | 6.1M | 2.83B |
Total current liabilities | 27.29B | 17.13B | 15.05B | 12.48B | 11.77B | 11.88B | 14.53B | 10.98B | 8.22B | 11.20B |
| Non-current liabilities: | ||||||||||
Long term debt | 18.32B | 14.73B | 15.34B | 16.58B | 14.30B | 9.19B | 9.94B | 8.36B | 7.97B | 5.33B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 7.52B | 6.75B | 1.64B | 1.70B | 1.01B | 11.91B | 8.83B | 5.37B | 4.77B | 5.24B |
Total non-current liabilities | 25.84B | 21.57B | 24.59B | 28.32B | 24.81B | 21.11B | 18.77B | 13.73B | 12.74B | 10.58B |
Total liabilities | 53.14B | 38.71B | 39.65B | 40.80B | 36.58B | 32.99B | 33.31B | 24.72B | 20.97B | 21.79B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |